Back to list

Ruling in Risperdal case does not affect Taiwan users: official

2012/04/12 18:26:35

Taipei, April 12 (CNA) Taiwan's Department of Health said Thursday that local patients using the drug Risperdal would not be affected by a ruling in the United States that fined Johnson & Johnson and a subsidiary, the drug's manufacturer, for improperly marketing the drug and downplaying its potential health risks.

Access to articles dating back more than six months is not available free of charge. You can gain access by becoming a paid Focus Taiwan member.